Clinical Trial Update: The Effect of Oral Alpha-Cyclodextrin on Fecal Fat Excretion [NA]

View source ↗

Summary

This clinical trial evaluating the effect of oral alpha-cyclodextrin on fecal fat excretion in obesity and cardiovascular disease has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Obesity

Drugs mentioned

• Alpha-Cyclodextrin (alpha-cyclodextrin)

Snippet

Sponsor: Pennington Biomedical Research Center | Conditions: Obesity, Cardiovascular Disease | NA | Status: WITHDRAWN